Summary
- Citigroup’s stock is undervalued, with a huge disconnect between market valuation and company guidance.
- Sentiments on the institutional side are beginning to change, with bullish views on C stock emerging.
- Near-term catalysts include Q4-2023 earnings and the Fed’s release of the annual CCAR stress tests in June 2024.
My recent Citigroup (NYSE:C) article described it as an asymmetric risk-rewards opportunity. The stock was trading at less than 0.6x tangible book value (“TBV”) which indicates that Mr. Market was assuming a return on tangible common equity (“RoTCE”) at around mid-single-digit.
Whereas the management team is guiding for 11% to 12% RoTCE in the 2025-2026 period. There remains a huge disconnect between what the market valuation is implying and the guidance by the company. This has to converge in the next 12 to 18 months one way or another.
READ FULL ARTICLE HERE!